With high UV levels continuing in Queensland this autumn, young people are at risk of suffering the worst skin damage they will receive during their lifetime, research from Queensland University of Technology (QUT) has found.

Thousands of Australians will avoid a premature death thanks to $50 million in new funds for bowel cancer screening announced in the lead-up to the federal budget, Cancer Council Australia said today.

The combination of two inhibitors of protein mTOR stops the growth of primary liver cancer and destroys tumour cells, according to a study by researchers of the Group of Metabolism and Cancer at Bellvitge Biomedical Research Institute (IDIBELL). The study results are been published on the online edition of the journal Science Translational Medicine.

This Mother’s Day, youth cancer charity CanTeen reaches out to young Australians aged 12-24 who have been devastated by their mum’s cancer diagnosis.

Despite widespread belief to the contrary, as few as 6 percent of women experience cancer-related persistent fatigue a year after undergoing treatment for breast cancer, a new study has found.

Researchers at Moffitt Cancer Center and colleagues at the University of South Florida and University of Kentucky have found that breast cancer survivors who have had chemotherapy, radiation or both do not perform as well on some cognitive tests as women who have not had cancer.

Australian women with advanced ovarian cancer have a new treatment option for their disease. The anti-cancer treatment, Avastin (bevacizumab), is now approved by the Therapeutic Goods Administration (TGA) in combination with chemotherapy (carboplatin and paclitaxel) for the treatment of patients with newly diagnosed (first-line) advanced epithelial ovarian, fallopian tube or primary peritoneal ...

A multi-national research team led by scientists at Duke-NUS Graduate Medical School has identified the reason why some patients fail to respond to some of the most successful cancer drugs.

Scientists have identified a new compound that rapidly kills hepatocellular carcinoma (HCC) cells, the most common form of liver cancer and fifth most common cancer worldwide, while sparing healthy tissue. The compound, Factor Qunolinone Inhibitor 1 (FQI1), works by inhibiting an oncogene originally discovered by a team of researchers led by Devanand Sarkar, M.B.B.S., Ph.D., Harrison Scholar ...

Dietary cadmium, a toxic metal widely dispersed in the environment and found in many farm fertilisers, may lead to an increased risk of breast cancer, according to a study published in Cancer Research, a journal of the American Association for Cancer Research.